Variant report
Variant | nsv546309 |
---|---|
Chromosome Location | chr1:58722310-58742150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:58722416..58724317-chr1:58724409..58727199,2 | K562 | blood: | |
2 | chr1:58722434..58724317-chr1:58724409..58727876,3 | K562 | blood: | |
3 | chr1:58722416..58724317-chr1:58724409..58727199,2 | K562 | blood: | |
4 | chr1:58722434..58724317-chr1:58724409..58727876,3 | K562 | blood: | |
5 | chr1:58740800..58743267-chr1:58744921..58746475,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542511 | chr1:58722310-58722311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs375142623 | chr1:58722351-58722352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554196427 | chr1:58722371-58722372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573914899 | chr1:58722388-58722389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146260467 | chr1:58722391-58722392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35629232 | chr1:58722409-58722410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72277529 | chr1:58722410-58722411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553273051 | chr1:58722432-58722433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12132541 | chr1:58722463-58722464 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs542864561 | chr1:58722470-58722471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138142119 | chr1:58722493-58722494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561268392 | chr1:58722554-58722555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75847722 | chr1:58722572-58722573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11207180 | chr1:58722598-58722599 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs544742774 | chr1:58722631-58722632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572875194 | chr1:58722641-58722642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375120811 | chr1:58722646-58722647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561332392 | chr1:58722703-58722704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530202045 | chr1:58722721-58722722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546803488 | chr1:58722740-58722741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550089192 | chr1:58722745-58722746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71642157 | chr1:58722748-58722749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17117197 | chr1:58722753-58722754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs7536463 | chr1:58722775-58722776 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs114098922 | chr1:58722824-58722825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537418039 | chr1:58722911-58722912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547949826 | chr1:58723011-58723012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547893851 | chr1:58723020-58723021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567847951 | chr1:58723053-58723054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533618928 | chr1:58723070-58723071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72910488 | chr1:58723089-58723090 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs573318848 | chr1:58723092-58723093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539324704 | chr1:58723124-58723125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566040462 | chr1:58723156-58723157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558961359 | chr1:58723213-58723214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs590047 | chr1:58723248-58723249 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs555675619 | chr1:58723302-58723303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540345117 | chr1:58723393-58723394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376075654 | chr1:58723394-58723395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544652812 | chr1:58723467-58723468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554981388 | chr1:58723501-58723502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575034492 | chr1:58723510-58723511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540360445 | chr1:58723511-58723512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148634173 | chr1:58723521-58723522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17117200 | chr1:58723558-58723559 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs185583777 | chr1:58723571-58723572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113198166 | chr1:58723603-58723604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188927372 | chr1:58723615-58723616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17440773 | chr1:58723623-58723624 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs367726793 | chr1:58723650-58723651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:58722000-58723000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:58722800-58723800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr1:58723000-58724200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr1:58723600-58724000 | Enhancers | Fetal Brain Male | brain |
5 | chr1:58723800-58724000 | Enhancers | Ovary | ovary |
6 | chr1:58723800-58724200 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
7 | chr1:58724000-58724400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr1:58724000-58759600 | Weak transcription | Ovary | ovary |
9 | chr1:58731000-58731400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr1:58740200-58740600 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr1:58740200-58740600 | Active TSS | H9 Cell Line | embryonic stem cell |
12 | chr1:58740200-58740600 | Active TSS | Placenta | Placenta |
13 | chr1:58740200-58740800 | Active TSS | HUES64 Cell Line | embryonic stem cell |
14 | chr1:58740200-58740800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
15 | chr1:58740200-58741000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr1:58740200-58741000 | Active TSS | HUES48 Cell Line | embryonic stem cell |
17 | chr1:58740200-58741000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
18 | chr1:58740800-58741000 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
19 | chr1:58741600-58741800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
20 | chr1:58741800-58749600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |